Clinical Trial

Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients

Study acronym: DREAMS
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Delirium is a common consequence of cardiac surgery and associates with poor outcomes. Multiple causes can trigger delirium occurence, and it has been hypothesised that sleep disturbances can be one of them. Dexmedetomidine may be effective in reducing delirium. The aim of this study was to demonstrate preoperative dexmedetomidine nasal spray in cardiac surgery patients can reduce postoperative delirium by improving preoperative sleep.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-09-28; most recent amendment 2025-07-17.
Status change: Not Yet Recruiting → Recruiting 2025-03-03
Trial Details
NCT Number NCT06619912
Lead Sponsor Xijing Hospital
Conditions Postoperative Delirium, Preoperative Sleep Disorder
Enrollment 686 participants
Start Date 2025-03-03
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05